Clinical Trial Update: Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mangafodipir as an add-on to FOLFOX6 chemotherapy in Dukes' C colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Mangafodipir (Mangafodipir trisodium)

Snippet

Sponsor: Egetis Therapeutics | Conditions: Chemotherapy, Colon Cancer | Phase 2 | Status: COMPLETED